Clinical trial · Observational
A Study on the Pathogenesis and Determinants of Intravenous Leiomyomatosis
NCT06773819CI-TRIAL-00086633not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observational study is to learn about the impact of HPV infection in women with intravenous leiomyomatosis(IVL). The main question it aims to answer is: Does HPV infection promote the development of IVL from uterine leiomyoma? Surgical sections and HPV-DNA test results will be collected in participants diagnosed with IVL or uterine leiomyoma.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| HPV Infection | — | UNRESOLVED | — |
| Intravenous Leiomyomatosis | Intravenous Leiomyomatosis | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- HPV-DNA test result
- timeFrame
- From date of enrollment until the date of surgery at PUMCH or date of death from any cause, whichever came first, assessed up to 100 months
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult female patients with suspected IVL or uterine leiomyoma who receive surgery at PUMCH * Be able to understand and sign the informed consent Exclusion Criteria: * Patients with other concurrent malignant tumors * Pregnant or lactating female * Postoperative pathology do not include IVL or uterine leiomyoma
References
Publications (0)
Data not yet available
No reference posted for this study.